Form 8-K - Current report:
SEC Accession No. 0000950170-24-125336
Filing Date
2024-11-12
Accepted
2024-11-12 16:05:15
Documents
14
Period of Report
2024-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K clym-20241112.htm   iXBRL 8-K 54172
2 EX-99.1 clym-ex99_1.htm EX-99.1 107512
3 EX-99.2 clym-ex99_2.htm EX-99.2 299743
4 GRAPHIC img109660168_0.jpg GRAPHIC 18656
  Complete submission text file 0000950170-24-125336.txt   665002

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT clym-20241112.xsd EX-101.SCH 50242
16 EXTRACTED XBRL INSTANCE DOCUMENT clym-20241112_htm.xml XML 4884
Mailing Address 20 WILLIAM STREET SUITE 145 WELLESLEY HILLS MA 02481
Business Address 20 WILLIAM STREET SUITE 145 WELLESLEY HILLS MA 02481 1-866-857-2596
Climb Bio, Inc. (Filer) CIK: 0001768446 (see all company filings)

EIN.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40708 | Film No.: 241447936
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)